The Global Pain Management Drugs Market is estimated to be USD 79.8 Bn in 2022 and is expected to reach USD 100.69 Bn by 2027, growing at a CAGR of 4.76%.
Market Segmentations
The Global Pain Management Drugs Market is segmented based on Drug Class, Indication, Pain Type, and Geography.
By Drug Class, the market is classified into NSAIDS, Anesthetics, Anticonvulsants, Antimigraine drug, Antidepressant drugs, Opioids, and Non-narcotic analgesics.
By Indication, the market is classified into Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, and Others.
By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.
Countries Studied
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Pain Management Drugs Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global Pain Management Drugs Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Report Highlights:
A complete analysis of the market, including the parent industry
Important market dynamics and trends
Market segmentation
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
Market Dynamics
Drivers
Rise in Incidences of Chronic Diseases
Favorable Regulatory Scenario
Increase in Geriatric Population
Restraints
Availability of Alternative Therapies
Patent Expiration of Prescription Drugs
Opportunities
Advancements in Drug Development
Untapped Markets in Developing Economies
Challenges
Drug Exploitation
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Pain Management Drugs Market, By Drug Class
7 Global Pain Management Drugs Market, By Indication
8 Global Pain Management Drugs Market, By Pain Type
9 Americas' Pain Management Drugs Market
10 Europe's Pain Management Drugs Market
11 Middle East and Africa's Pain Management Drugs Market
12 APAC's Pain Management Drugs Market
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
Abbott Laboratories
Allergen Inc Baxter International Inc Boehringer Ingelheim
Bristol-Myers Squibb Company
Eli Lilly and Company
Endo Health Solutions Inc GlaxoSmithKline plc
Johnson & Johnson Services Inc Merck & Co. Inc Mylan NV
Novartis AG
Pfizer Inc Purdue Pharma L.P.
Sanofi S.A
Sorrento Therapeutics
Teva Pharmaceutical Industries Ltd
Valeant Pharmaceuticals International Inc WEX Pharmaceuticals
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to ResearchAndMarkets.com's offering.
Infectious disease Dx is...
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
Will all...
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...
The "Agricultural Sprayers - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Agricultural Sprayers estimated at US$2.4 Billion in the year 2023, is projected to reach a revised size of...
The "Prepaid Cards - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Prepaid Cards estimated at US$2 Trillion in the year 2023, is projected to reach a revised size of US$4.1 Trillion by...